Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who speak and understand English fluently
- People who live in Marion County
- People between the ages of 35 and 75
- People who identify as non-Hispanic and Black, African-American, or biracial including African-American
- People who had a blood pressure reading of 140 or higher (top number) at a primary care visit in the past 12 months
- People who are able to see and read street signs (based on self-report)
- People who have stable housing with their own access to a kitchen that has a working stove or hotplate, oven, refrigerator, and freezer (based on self-report)
- People who can manage everyday tasks largely on their own, based on a standard questionnaire about daily activities
- People who score well on a short memory and thinking screening test
- People who do less than 20 minutes of moderate or vigorous physical activity on a typical day
- People who are cleared to exercise safely, either through a short exercise screening tool or with approval from their primary care doctor
- People whose blood pressure measures 130 or higher (top number) on average across three readings taken by research staff under standardised conditions
Who may not be able to join:
- People who live in a nursing home
- People with a diagnosis of dementia, Alzheimer's disease, mild cognitive impairment, Parkinson's disease, a brain tumour, brain infection, or brain surgery within the last 10 years that left lasting symptoms or difficulties with learning, memory, or communication; cancer with a short life expectancy; current chemotherapy or radiation treatment; or psychosis, schizophrenia, or bipolar disorder
- People whose medical records show certain specific types of high blood pressure-related heart or kidney disease (confirm with trial site)
- People who are currently taking or have previously been prescribed the medications donepezil, memantine, rivastigmine, or galantamine (medications commonly used for memory conditions)
- People who drink 8 or more alcoholic drinks per week (for women) or 15 or more per week (for men)
- People whose medical records indicate non-marijuana drug use or misuse
- People who plan to move out of the area during the study period
- People whose schedules conflict with the intervention timetable
- People who are unwilling to use a touchscreen device
- People who are unwilling to participate in video calls
- People whose ability to communicate, level of daily functioning, or other conditions would interfere with taking part in the study activities (as assessed by the examiner)
- People who are unable to provide informed consent
- People who are currently participating in a lifestyle change or weight loss programme (such as Weight Watchers or similar)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Daniel O Clark, PhD, Indiana University
Phone: 317-274-9292
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Cognitive function composite score as measured by individually-administered tests of psychomotor speed, complex sequencing, semantic fluency, interference and list learning and delayed recall at Week 28.; Cognitive function composite score as measured by individually-administered tests of psychomotor speed, complex sequencing, semantic fluency, interference and list learning and delayed recall at Week 52.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.